SYS-CON MEDIA Authors: PR.com Newswire, David Smith, Tim Crawford, Kevin Benedict, Gilad Parann-Nissany

News Feed Item

New Research Facility, Results Release Schedule, Sales Transaction Closure, Financial Results, and Bond Issuance - Analyst Notes on DuPont, Monsanto, CF Industries, Yongye, and Syngenta

Editor Note: For more information about this release, please scroll to bottom.

NEW YORK, March 31, 2014 /PRNewswire/ --

Today, Analysts Review released its analysts' notes regarding E. I. du Pont de Nemours and Company (NYSE: DD), Monsanto Company (NYSE: MON), CF Industries Holdings, Inc. (NYSE: CF), Yongye International, Inc. (NASDAQ: YONG), and Syngenta AG (NYSE: SYT). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.AnalystsReview.com/register

E. I. du Pont de Nemours and Company Analyst Notes  

On March 26, 2014, E. I. du Pont de Nemours and Company's (DuPont) Chairman and CEO, Ellen Kullman, unveiled a newly expanded research facility of the Company in Delmas, South Africa, which will serve as the core of the DuPont Africa regional technology center. The Company notified that the technology center aims to help advance DuPont's ongoing efforts to accelerate seed product development for African farmers and help them better manage key agronomic challenges. Ellen Kullman said, "Agriculture has a vital role to play in the social and economic security of African countries. We are harnessing DuPont's global science capabilities and resources to create local solutions that improve productivity for farmers in South Africa and throughout the continent," He added, "We believe this technology center will be a catalyst for innovation and collaboration to help feed a growing population in Africa and around the world." The full analyst notes on E. I. du Pont de Nemours and Company are available to download free of charge at:

http://www.AnalystsReview.com/03312014/DD/report.pdf

Monsanto Company Analyst Notes 

On March 26, 2014, Monsanto Company (Monsanto) announced that it intends to release its Q2 FY 2014 financial results on April 2, 2014, before the market opens. The Company informed that it has also scheduled a conference call on the same day at 8:30 a.m. CT / 9:30 a.m. ET to discuss the results and its future expectations. According to Monsanto, the call may further include a discussion of the Company's strategic initiatives, product performance and other matters related to its business. An audio webcast of the conference call may be accessed by interested parties via the Investor section of Monsanto's web site. The full analyst notes on Monsanto Company are available to download free of charge at:

http://www.AnalystsReview.com/03312014/MON/report.pdf

CF Industries Holdings, Inc. Analyst Notes 

On March 17, 2014, CF Industries Holdings, Inc. (CF Industries) announced that it has completed the sale of its phosphate business to The Mosaic Company (Mosaic) for $1.4 billion or c. $1.0 billion net of taxes and other adjustments. "The net proceeds from the sale will be redeployed to execute the strategic initiatives we already have in progress, namely our nitrogen capacity expansions and completing our share repurchase authorization. Additionally, the supply agreements we have put in place with Mosaic will provide us a steady base of ammonia demand with attractive economics," said Tony Will, President and CEO of CF Industries. Additionally, the Company informed that after the closure of the sale transaction, it will begin to supply Mosaic with its share of the ammonia produced CF Industries' 50% owned production facility in the Republic of Trinidad and Tobago. The Company added that it is into a long-term supply agreement with Mosaic to supply 600,000 to 800,000 tons of ammonia per year for up to 15 years from its Donaldsonville nitrogen complex. The full analyst notes on CF industries Holdings, Inc. are available to download free of charge at:

http://www.AnalystsReview.com/03312014/CF/report.pdf

Yongye International, Inc. Analyst Notes 

On March 17, 2014, Yongye International, Inc. (Yongye) announced its Q4 2013 and full-year 2013 financial results. In Q4 2013, the Company's revenue increased 29.2% YoY to $92.0 million, while full-year 2013 revenue increased 49.4% YoY to $661.9 million. Q4 2013 net income attributable to Yongye was $14.6 million, or $0.24 per diluted share, compared to $19.4 million, or $0.32 per diluted share, in Q4 2012. Full-year 2013 net income attributable to the Company was $170.8 million, or $2.93 per diluted share, compared to $93.7 million, or $1.62 per diluted share, in full year 2012. "We are pleased with our overall performance in 2013. Our growth was in line with expectations, our branded retailer network exceeded the target of 36,000 and we also achieved positive cash flow from operations for the full year," said Zishen Wu, Chairman and CEO of Yongye. The full analyst notes on Yongye International, Inc. are available to download free of charge at:

http://www.AnalystsReview.com/03312014/YONG/report.pdf

Syngenta AG Analyst Notes 

On March 25, 2014, Syngenta AG (Syngenta) announced the successful issue of CHF750 million in Swiss domestic bonds. The Company notified that the issue comprises of a CHF350 million Swiss domestic bond, maturing in November 2019; a CHF250 million Swiss domestic bond that will mature in November 2024, and a CHF150 million Swiss domestic bond that will mature in November 2029. "We have taken advantage of current favorable market conditions in order to further enhance our debt maturity profile. These bond issues are part of our normal funding requirements and the positive market reception demonstrates Syngenta's strong credit quality," said John Ramsay, CFO of Syngenta. The full analyst notes on Syngenta AG are available to download free of charge at:

http://www.AnalystsReview.com/03312014/SYT/report.pdf


About Analysts Review
We provide our members with a simple and reliable way to leverage our economy of scale. Most investors do not have time to track all publicly traded companies, much less perform an in-depth review and analysis of the complexities contained in each situation. That's where Analysts Review comes in. We provide a single unified platform for investors' to hear about what matters. Situation alerts, moving events, and upcoming opportunities.

=============

EDITOR NOTES: 

  • This is not company news. We are an independent source and our views do not reflect the companies mentioned.
  • Information in this release is fact checked and produced on a best efforts basis and reviewed by Nidhi Vatsal, a CFA charterholder. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.
  • This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.
  • If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco [at] AnalystsReview.com.
  • For any urgent concerns or inquiries, please contact us at compliance [at] AnalystsReview.com.
  • Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research [at] AnalystsReview.com for consideration.

COMPLIANCE PROCEDURE 

Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Analysts Review. An outsourced research services provider represented by Nidhi Vatsal, CFA, has only reviewed the information provided by Analysts Review in this article or report according to the Procedures outlined by Analysts Review. Analysts Review is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.

NOT FINANCIAL ADVICE 

Analysts Review makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.

NO WARRANTY OR LIABILITY ASSUMED 

Analysts Review is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Analysts Review whatsoever for any direct, indirect or consequential loss arising from the use of this document. Analysts Review expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Analysts Review does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

http://www.AnalystsReview.com


SOURCE Analysts Review

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.